Bone metastases of bronchial cancer

T. Adzic, G. Radosavljevic-Asic, N. Samardzic, S. Filipovic, D. Jovanovic (Belgrade, Yugoslavia)

Source: Annual Congress 2002 - Lung cancer: epidemiology and clinical characteristics
Session: Lung cancer: epidemiology and clinical characteristics
Session type: Thematic Poster Session
Number: 576
Disease area: Thoracic oncology

Congress or journal article abstract

Abstract

During 2000, 1044 pts with malignant lung tumors were analyzed, out of whom 47(5%) had bone metastases, 36(77%) males aged 58 years on average and 11(23%) females mean age 61 years. The diagnosis of malignant tumor was made in 24(51%) by bronchologic tests, in 4(9%) by FNAB of lung changes, in 4(9%) cases by bone biopsy, in 3(6%) pts by exploratoy thoracotomy, in 2(4%) by lymph node biopsy, while diagnosis could not be made in 10(21%) cases. Histopathologic findings were as follows: Adenocarcinoma was found in 18(38%)pts, Squamous Cell Carcinoma in 14(30%), Small Cell Lung Carcinoma in 4(9%), Bronchioalveolar Carcinoma in 1(2%) patient, and no diagnosis was made in 10(21%) cases. After the surgery, bone metastases were detected in 6 pts, and accordingly, symptomatic treatment was applied in 3 pts, one received chemotherapy, one had radiation therapy, and there was one lethal outcome. The remaining 10(21%) cases were administered chemotherapy, 3(6%) pts were given radiation therapy, 1(2%) received combined chemo and radiation therapy, 22(47%) of them had symptomatic treatment, while 5(11%) cases died during the diagnosis. The diagnosis was based on bone radiography and scintigraphy. Higher level of alkaline phosphatase in serum was found in all pts(100%). The bones most frequently involved were: ribs, vertebrae, humerus and femur. It may be concluded that Adenocarcinoma was the most frequent type of tumor to metastasize in bones, the most common aspect of therapy was palliative treatment, lethal outcome during diagnosis occurred in 5(11%) cases, while pamidronate was successfully applied in one patient who had undergone surgery and received chemotherapy.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Adzic, G. Radosavljevic-Asic, N. Samardzic, S. Filipovic, D. Jovanovic (Belgrade, Yugoslavia). Bone metastases of bronchial cancer. Eur Respir J 2002; 20: Suppl. 38, 576

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Detection of bone metastases in patients with lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 65s
Year: 2001

Survival of lung cancer patients with bone metastases
Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Year: 2011

Bone metabolic markers in detecting bone metastasis of lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

Usefulness of bone metabolic markers in the bone metastasis from lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 269s
Year: 2002

The role of bisphosphonates in lung cancer patients with bone metastases
Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology
Year: 2007


Splenic metastasis of lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 91s
Year: 2006

Bone marrow metastases in non-small cell lung cancer patients – a role of flow cytometry
Source: Eur Respir J 2006; 28: Suppl. 50, 782s
Year: 2006

Brain metastases in lung cancer patients
Source: International Congress 2019 – ME4 Brain metastases in lung cancer patients.
Year: 2019


Palliation of bone metastases-related pain in lung carcinoma
Source: Eur Respir J 2003; 22: Suppl. 45, 66s
Year: 2003

Detection of bone metastases in patients with NSCLC
Source: Eur Respir J 2002; 20: Suppl. 38, 185s
Year: 2002

Unusual metastases in lung cancer
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013


Lung metastases revealing medulloblastoma
Source: Eur Respir J 2005; 26: Suppl. 49, 539s
Year: 2005

Comparision of FDG PET/CT and bone scanning for bone metastases in operable non-small cell lung cancer
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

Endobronchial metastasis from breast cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 77s
Year: 2006

Endobronchial metastasis from prostate cancer
Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology
Year: 2007


Detecting extrathoracic metastases in patients with non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 41s
Year: 2006

Lung cancer after lung transplantation
Source: Annual Congress 2007 - Complications and success in lung transplantation
Year: 2007


Lung carcinoma and verthebral column metastases
Source: Eur Respir J 2007; 30: Suppl. 51, 428s
Year: 2007

Lung cancer and pleural mesothelioma
Source: Eur Respir Monogr 2014; 65: 48-60
Year: 2014